A nurse is preparing to administer disulfiram 375 mg PO once daily. Available is disulfiram 250 mg tablets. How many tablets should the nurse administer? (Round the answer to the nearest tenth. Use a leading zero if it applies. Do not use a trailing zero.)

A. Risperidone is an antipsychotic medication used to treat conditions like schizophrenia and bipolar disorder. It is not indicated for smoking cessation and does not have any direct effect on nicotine withdrawal or cravings. Therefore, it would not be included in discussions about smoking cessation medications.
B. Bupropion is a medication that is FDA-approved for smoking cessation. It works by reducing nicotine cravings and withdrawal symptoms. It is available in sustained-release formulations specifically marketed for smoking cessation under the brand name Zyban. Bupropion can be effective in helping individuals quit smoking and is often recommended as a first-line treatment.
C. Aripiprazole is an antipsychotic medication used primarily to treat conditions such as schizophrenia, bipolar disorder, and major depressive disorder. It does not have any specific indication or role in smoking cessation. Therefore, it would not typically be included in discussions about medications for quitting smoking.
D. Quetiapine is another antipsychotic medication used to treat conditions like schizophrenia, bipolar disorder, and major depressive disorder. Similar to aripiprazole and risperidone, it does not have any direct role in smoking cessation. It is not indicated for reducing nicotine cravings or aiding in smoking cessation efforts.

A. This statement is incorrect. Under the Health Insurance Portability and Accountability Act (HIPAA) in the United States and similar privacy laws in other countries, healthcare providers are generally prohibited from disclosing a client's health information to their employer without the client's explicit consent.
B. This statement is correct. HIPAA and other privacy laws extend confidentiality protections beyond a client's death. Healthcare providers are still obligated to protect the confidentiality of deceased individuals' health information, unless certain exceptions apply (e.g., public health reasons or legal requirements).
C. Consent from a provider is not sufficient for discussing health information with a client's family; the consent must come from the client or their legal representative.
D. While it is generally good practice to obtain consent from the client before disclosing health information to their family members, there are circumstances where healthcare providers can share information with family members without consent.